Harpoon: Arix Bioscience eyes USD19 million return from Harpoon sale

(marketscreener.com) Arix Bioscience PLC - London-based venture capital firm investing in "breakthrough" biotechnology companies - Expects USD18.6 million net proceeds from its USD680 million sale of Harpoon Therapeutics, a clinical-stage immunotherapy company, to Rahway, New Jersey-based pharmaceutical maker Merck & Co Inc. Anticipates transaction to close in...https://www.marketscreener.com/quote/stock/ARIX-BIOSCIENCE-PLC-34067690/news/Arix-Bioscience-eyes-USD19-million-return-from-Harpoon-sale-45774705/?utm_medium=RSS&utm_content=20240119